Pioneer in Smart Sleep Medicine, offering non-CPAP alternatives for Obstructive Sleep Apnea.
About
ProSomnus provides a technology-enabled, non-CPAP alternative for Obstructive Sleep Apnea (OSA) treatment using precision oral appliance therapy. Their FDA-cleared devices integrate with remote patient monitoring and data-driven diagnostics to improve adherence and patient outcomes, targeting a significant global market affected by OSA.
Tags
Performance
Company Timeline
No timeline data for this period
Score Breakdown
54Traction
38Team
70Visibility
0Profile
0Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does ProSomnus do?
ProSomnus provides a technology-enabled, non-CPAP alternative for Obstructive Sleep Apnea (OSA) treatment using precision oral appliance therapy. Their FDA-cleared devices integrate with remote patient monitoring and data-driven diagnostics to improve adherence and patient outcomes, targeting a significant global market affected by OSA.
How much funding has ProSomnus raised?
ProSomnus has raised a total of $48M in funding. The most recent round on record is Strategic Investment.
Where is ProSomnus headquartered?
ProSomnus is headquartered in Pleasanton, United States.
When was ProSomnus founded?
ProSomnus was founded in 2016.
What industry does ProSomnus operate in?
ProSomnus operates in Medical Devices, HealthTech, Sleep Medicine.